Study On The Comprehensive Evaluation System Of Drug Manufacturing Enterprise

With the economic and social development, improvement of people's income levels and the aging of the population, China's pharmaceutical industry has maintained a high growth rate, and the economic operation quality and efficiency improved. Meanwhile, as the in-depth implementation of the new health reform policy, as well as the improvement of the basic drug system and the public hospitals reformation, people's medication needs has constantly released, making China's pharmaceutical market to expand rapidly. It is an opportunity and a challenge to China's pharmaceutical industry. However, the pharmaceutical production of China always have the problem of "low-level redundant", that is, the industry target is not clear, the competition is not standardized, no company could really be called the "industry flagship", government policy do not have clear supporting target, and the real strength companies can not quickly come to the fore. Therefore, the industry urgently needs an objective evaluation criterion to grasp the pharmaceutical production companies as a whole, to regulate the trade order, to make the enterprises know themselves, and to provide the basis for the development strategy adjustment, partner identification, and reorganization of competitors. At the same time, for the medicines used in medical institutions were purchased by centralized bidding, a clear evaluation system is in need in this trading platform to regulate the competition between pharmaceutical manufacturers, so that quality and cheap drugs made by real good business could win the bid. This objective requires the existence of a comprehensive evaluation system to provide information and guarantee for the development and implementation of government medical policy.This research analyzes the classical theories and models of domestic and foreign enterprises comprehensive evaluation to draw on their research methods and ideas, and determine the principle of pharmaceutical company's comprehensive evaluation based on the industry background and policy background in China. In the light of comprehensive evaluation theory, the establishment of comprehensive evaluation system requires the definition of the evaluation index system and the index weights. In the third part, the frequency analysis was employed to analyze the published comprehensive evaluation system, the highest frequency indicators was selected as financial indicators. At the same time, resolve the pharmaceutical manufacturing evaluation purpose using decomposition method, in order to get the innovation, quality assurance system and social responsibility indicators. The final target system was made after expert optimization. In the fourth section, the index weight was calculated according to different levels and a complete comprehensive evaluation index system was established. In the fifth section, a complete comprehensive evaluation model was developed after selection of appropriate data processing method and scoring method. Data of five sample enterprises were selected, and a comprehensive evaluation road show was carried out according to the model. The use of company comprehensive evaluation model was displayed in a specific and visual way.